89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

NCT04566978 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma
DLBCL

Interventions

DRUG: 89Zr-DFO-REGN3767
DIAGNOSTIC_TEST: PET/CT

Sponsor

Memorial Sloan Kettering Cancer Center